3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Bone Tumor: new trials by email Literature Review of Bone Tumor trials Research Report on Bone Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults MW032, Xgeva® - Bone Tumor | Phase 1 | Completed | Mabwell (Shanghai) Bioscience Co., Ltd. | 120 | 2019-06-25 | 2021-03-15 |
| Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) trabectedin, olaparib - Soft Tissue Sarcoma, Bone Tumor | Phase 1 | Completed | Italian Sarcoma Group | 50 | 2014-07-20 | 2021-04-14 |
| Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Microwave ablation with Acculis Accu2i pMTA Applicator - Lung Tumor, Bone Tumor | Phase 1 / Phase 2 | Completed | Centre Hospitalier Universitaire de Besancon | 30 | 2012-09-01 | 2016-08-11 |
Bone Neoplasms (3) · Carcinoma, Renal Cell (1) · Lung Neoplasms (1) · Sarcoma (1)
Bone Diseases (3) · Musculoskeletal Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Neoplasms by Histologic Type (2) · Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Lung Diseases (1) · Male Urogenital Diseases (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1)
Denosumab (1) · Trabectedin (1) · olaparib (1)
Centre Hospitalier Universitaire de Besancon (1) · Italian Sarcoma Group (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1)
China (1) · France (1) · Italy (1)